DZ629A1 - Dérivés de la furo-(3,4-c)-pyridine ainsi que leurpréparation. - Google Patents

Dérivés de la furo-(3,4-c)-pyridine ainsi que leurpréparation.

Info

Publication number
DZ629A1
DZ629A1 DZ847143A DZ847143A DZ629A1 DZ 629 A1 DZ629 A1 DZ 629A1 DZ 847143 A DZ847143 A DZ 847143A DZ 847143 A DZ847143 A DZ 847143A DZ 629 A1 DZ629 A1 DZ 629A1
Authority
DZ
Algeria
Prior art keywords
furo
preparation
pyridine derivatives
pyridine
derivatives
Prior art date
Application number
DZ847143A
Other languages
English (en)
Inventor
Andre Esanu
Original Assignee
Ct De Conseils De Rech Et D Ap
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838327815A external-priority patent/GB8327815D0/en
Application filed by Ct De Conseils De Rech Et D Ap filed Critical Ct De Conseils De Rech Et D Ap
Application granted granted Critical
Publication of DZ629A1 publication Critical patent/DZ629A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
DZ847143A 1983-04-05 1984-04-01 Dérivés de la furo-(3,4-c)-pyridine ainsi que leurpréparation. DZ629A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8309165 1983-04-05
GB838327815A GB8327815D0 (en) 1983-10-18 1983-10-18 Furo-(3 4-c)-pyridine derivatives

Publications (1)

Publication Number Publication Date
DZ629A1 true DZ629A1 (fr) 2004-09-13

Family

ID=26285725

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ847143A DZ629A1 (fr) 1983-04-05 1984-04-01 Dérivés de la furo-(3,4-c)-pyridine ainsi que leurpréparation.

Country Status (29)

Country Link
US (1) US4581363A (fr)
JP (1) JPS59193888A (fr)
KR (1) KR900005518B1 (fr)
AU (1) AU582113B2 (fr)
CA (1) CA1257269A (fr)
CH (1) CH660191A5 (fr)
DE (1) DE3412885C2 (fr)
DK (1) DK157931C (fr)
DZ (1) DZ629A1 (fr)
EG (1) EG18150A (fr)
ES (1) ES8601998A1 (fr)
FI (1) FI76804C (fr)
FR (2) FR2543956B1 (fr)
GR (1) GR79577B (fr)
HK (1) HK11187A (fr)
IE (1) IE57424B1 (fr)
IL (1) IL71243A (fr)
IN (1) IN160104B (fr)
IT (1) IT1173770B (fr)
LU (1) LU85262A1 (fr)
MA (1) MA20084A1 (fr)
MX (1) MX167397B (fr)
MY (1) MY8600664A (fr)
NL (1) NL190328C (fr)
NO (1) NO161802C (fr)
NZ (1) NZ207552A (fr)
OA (1) OA07699A (fr)
PT (1) PT78361B (fr)
SE (1) SE458362B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
DE3990349T1 (de) * 1988-04-06 1990-04-26 Scras Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
CA2366602A1 (fr) 1999-03-08 2000-09-14 Medicure Inc. Analogues de pyridoxal destines aux troubles provoques par une carence en vitamine b6
WO2001003682A2 (fr) * 1999-07-13 2001-01-18 Medicure Inc. Traitement du diabete et des pathologies associees
EP1210117A2 (fr) * 1999-08-24 2002-06-05 Medicure International Inc. Traitement des pathologies cardio-vasculaires et connexes
PT1268498E (pt) 2000-02-29 2005-07-29 Medicure Int Inc Fosfonatos cardioprotectores
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
EP1278526A2 (fr) 2000-03-28 2003-01-29 Medicure International Inc. Traitement d'une maladie vasculaire cerebrale
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
ATE364595T1 (de) 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
CA2570048A1 (fr) * 2004-07-07 2006-01-12 Medicure International Inc. Polytherapies faisant intervenir des inhibiteurs d'agregation plaquettaire
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
WO2006050598A1 (fr) * 2004-10-28 2006-05-18 Medicure International Inc. Analogues de pyridoxine à double activité anti-plaquettes et anti-coagulantes
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
AU2006317440A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use
GB2008582B (en) * 1977-11-25 1982-04-28 Scras Pyridine derivative
IN156817B (fr) * 1981-02-10 1985-11-09 Scras

Also Published As

Publication number Publication date
NZ207552A (en) 1986-05-09
FR2543829B1 (fr) 1986-11-21
EG18150A (en) 1992-08-30
IN160104B (fr) 1987-06-27
MY8600664A (en) 1986-12-31
CA1257269A (fr) 1989-07-11
KR840008651A (ko) 1984-12-17
OA07699A (fr) 1985-08-30
LU85262A1 (fr) 1984-10-24
US4581363A (en) 1986-04-08
NL190328B (nl) 1993-08-16
DK157931B (da) 1990-03-05
IE840826L (en) 1984-10-05
CH660191A5 (fr) 1987-03-31
MA20084A1 (fr) 1984-12-31
FI76804C (fi) 1988-12-12
AU582113B2 (en) 1989-03-16
GR79577B (fr) 1984-10-30
HK11187A (en) 1987-02-13
DK157931C (da) 1990-08-27
NO841322L (no) 1984-10-08
FR2543829A1 (fr) 1984-10-12
FI841273A0 (fi) 1984-03-30
JPS59193888A (ja) 1984-11-02
ES531285A0 (es) 1985-11-01
DE3412885A1 (de) 1984-10-11
FR2543956B1 (fr) 1986-07-04
DK178084A (da) 1984-10-06
IE57424B1 (en) 1992-09-09
FR2543956A1 (fr) 1984-10-12
DE3412885C2 (de) 1990-10-04
MX167397B (es) 1993-03-22
NL190328C (nl) 1994-01-17
NO161802C (no) 1989-09-27
IL71243A0 (en) 1984-06-29
IT8420396A0 (it) 1984-04-05
NO161802B (no) 1989-06-19
SE8401841D0 (sv) 1984-04-03
FI841273A (fi) 1984-10-06
DK178084D0 (da) 1984-04-04
SE8401841L (sv) 1984-10-06
JPH0556353B2 (fr) 1993-08-19
ES8601998A1 (es) 1985-11-01
IL71243A (en) 1987-12-20
PT78361A (en) 1984-05-01
PT78361B (en) 1986-05-28
AU2640184A (en) 1984-10-11
KR900005518B1 (ko) 1990-07-30
SE458362B (sv) 1989-03-20
FI76804B (fi) 1988-08-31
IT1173770B (it) 1987-06-24
NL8401013A (nl) 1984-11-01

Similar Documents

Publication Publication Date Title
DZ629A1 (fr) Dérivés de la furo-(3,4-c)-pyridine ainsi que leurpréparation.
DE19975020I2 (de) Pyridin-Derivate und deren Herstellung.
IT8219730A0 (it) Derivati 5-amminometil-ossazolidinici, procedimento per la loro preparazione, e loro applicazione in terapia.
IT1200092B (it) Derivati amminopropossi, loro preparazione e loro impiego come medicamenti
MX6983E (es) Procedimiento de preparacion de derivados 1,3-dihidro-6-metil-7-hidroxifuro-(3,4-c)-piridina
IT1200089B (it) Composti monoazoici, anionici, loro preparazione e loro impiego come coloranti
IT1231502B (it) Composti disazoici anionici, loro preparazione e loro impiego come coloranti.
MX9203090A (es) Derivados de finilisopropilamina y su preparacion.
IT8420841A0 (it) 1-pirimidinilossi-3-etarilalchilammino-2-propanoli, loro preparazione e loro impieghi.
IT1199973B (it) Composti dis-o trisazoici,loro preparazione e loro impiego come coloranti
ATE51232T1 (de) Tricyclische pyridonderivate.
ATE29881T1 (de) 4-hydroxy-2h-1-benzothiopyran-derivate, deren herstellungen und verwendungen.
DE3585315D1 (de) 5,6,7,8-tetrafluoranthrachinonderivate.
IT1199212B (it) Derivati dell'1,2-ditiolano,loro preparazione e loro impiego come medicamenti
IT8323925A0 (it) Derivati bezilidenici solforati, loro preparazione e loro applicazione in terapia.
ES536814A0 (es) Procedimiento de preparacion de nuevos derivados de 1, 3-dihidro-6-metil-7-hidroxi-furo-(3, 4-c)-piridina
IT1186667B (it) 2,1,3-benzotiadiazoli e 2,1,3-benzossadiazoli,loro preparazione e loro applicazione come medicamenti
IT8224306A0 (it) Derivati benzilidenici, loro preparazione e loro applicazione in terapia.
DE3586745D1 (de) 9,11-epoxy-21-hydroxypregnan-derivate.
IT1199237B (it) Composti bisazoici,loro preparazione e loro impiego come coloranti
DE3469732D1 (de) 3,5-dialkyl-4-hydroxyphenyl-substituted derivatives
IT1199949B (it) Diazepinoindoli,loro preparazione e loro impiego come medicamenti
IT8522259A0 (it) Idrossi-tia-alcheni, procedimentodi preparazione e applicazione degli stessi.
IT8522035A0 (it) Procedimento di preparazionedi derivati di 6-sostituita-furo-(3,4-c)-piridina.
IT8521744A0 (it) Alchilsolfonilpropeni, procedimento per la loro preparazione e loro impiego.